Fu Wang

1.7k total citations
31 papers, 1.3k citations indexed

About

Fu Wang is a scholar working on Molecular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Fu Wang has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Medicine, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Fu Wang's work include Antibiotic Resistance in Bacteria (8 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Immune cells in cancer (4 papers). Fu Wang is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Immune cells in cancer (4 papers). Fu Wang collaborates with scholars based in China, United States and Japan. Fu Wang's co-authors include Minggui Wang, Demei Zhu, Fupin Hu, Yingyuan Zhang, David C. Hooper, George A. Jacoby, John H. Tran, Shi Wu, Xiaofei Jiang and Yan Guo and has published in prestigious journals such as Cancer Research, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Fu Wang

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fu Wang China 13 723 280 270 266 233 31 1.3k
Hee Bong Shin South Korea 16 925 1.3× 302 1.1× 400 1.5× 190 0.7× 451 1.9× 51 1.5k
Ju‐Hsin Chia Taiwan 22 674 0.9× 389 1.4× 290 1.1× 157 0.6× 395 1.7× 43 1.5k
Ya‐Sung Yang Taiwan 22 569 0.8× 433 1.5× 248 0.9× 152 0.6× 275 1.2× 84 1.2k
Fernando Docobo-Pérez Spain 25 1.1k 1.5× 482 1.7× 331 1.2× 534 2.0× 327 1.4× 65 1.5k
Han-Sung Kim South Korea 23 486 0.7× 307 1.1× 364 1.3× 162 0.6× 215 0.9× 103 1.4k
Anna Di Popolo Italy 19 609 0.8× 165 0.6× 335 1.2× 289 1.1× 363 1.6× 22 1.2k
Hadir A. El‐Mahallawy Egypt 21 511 0.7× 345 1.2× 172 0.6× 133 0.5× 179 0.8× 53 1.1k
Francis S. Codjoe Ghana 10 533 0.7× 200 0.7× 93 0.3× 166 0.6× 213 0.9× 14 1.1k
Nan Bai China 9 715 1.0× 180 0.6× 190 0.7× 326 1.2× 184 0.8× 20 935
Paul Pantapalangkoor United States 13 1.1k 1.5× 247 0.9× 507 1.9× 155 0.6× 586 2.5× 16 1.6k

Countries citing papers authored by Fu Wang

Since Specialization
Citations

This map shows the geographic impact of Fu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Wang more than expected).

Fields of papers citing papers by Fu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Wang. The network helps show where Fu Wang may publish in the future.

Co-authorship network of co-authors of Fu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Fu Wang. A scholar is included among the top collaborators of Fu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fu Wang. Fu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fu, Haoyu You, Huahua Liu, et al.. (2025). Silencing PTPN2 with nanoparticle-delivered small interfering RNA remodels tumor microenvironment to sensitize immunotherapy in hepatocellular carcinoma. Acta Pharmaceutica Sinica B. 15(6). 2915–2929. 3 indexed citations
2.
Hu, Yucheng, et al.. (2025). Yu-Ping-Feng nasal drops relieve allergic rhinitis via TRPV1/Ca2+/NFAT pathway. Journal of Ethnopharmacology. 355(Pt A). 120618–120618.
3.
Yu, Zihua, et al.. (2025). PDK1-mediated phosphorylation of USP5 modulates NF-κB signalling to enhance osteosarcoma growth. International Journal of Biological Macromolecules. 306(Pt 1). 141378–141378. 1 indexed citations
4.
Weng, Jialei, Zheng Wang, Zhiqiu Hu, et al.. (2024). Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy. Cancer Research. 84(11). 1817–1833. 18 indexed citations
5.
Wang, Fu, Weiqi Xu, Wanqin Zhang, et al.. (2023). Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway. Hepatology International. 18(2). 636–650. 7 indexed citations
6.
Liu, Zhiyong, Guobo Chen, Xiang Wang, et al.. (2023). Synergistic Photochemo Effects Based on Light‐Activatable Dual Prodrug Nanoparticles for Effective Cancer Therapy. Advanced Healthcare Materials. 12(27). e2301133–e2301133. 10 indexed citations
7.
Wang, Fu, Jialei Sun, Guangcong Zhang, et al.. (2022). A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Journal of Translational Medicine. 20(1). 579–579. 2 indexed citations
8.
Wang, Xiang, Jialei Sun, Guangcong Zhang, et al.. (2022). Iridium Complex-Loaded Sorafenib Nanocomposites for Synergistic Chemo-photodynamic Therapy of Hepatocellular Carcinoma. ACS Applied Materials & Interfaces. 14(33). 37356–37368. 20 indexed citations
9.
Liu, Zhiyong, Danying Zhang, Xiahui Lin, et al.. (2022). Nalidixic acid potentiates the antitumor activity in sorafenib-resistant hepatocellular carcinoma via the tumor immune microenvironment analysis. Frontiers in Pharmacology. 13. 952482–952482. 3 indexed citations
10.
Sun, Jialei, Ning‐Ping Zhang, Guangcong Zhang, et al.. (2021). Tumor cell-imposed iron restriction drives immunosuppressive polarization of tumor-associated macrophages. Journal of Translational Medicine. 19(1). 347–347. 36 indexed citations
11.
Yao, Qunyan, Shuyu Li, Xi Li, Fu Wang, & Chuantao Tu. (2020). Myricetin Modulates Macrophage Polarization and Mitigates Liver Inflammation and Fibrosis in a Murine Model of Nonalcoholic Steatohepatitis. Frontiers in Medicine. 7. 71–71. 55 indexed citations
12.
Hu, Fupin, Yan Guo, Yang Yang, et al.. (2019). Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. European Journal of Clinical Microbiology & Infectious Diseases. 38(12). 2275–2281. 197 indexed citations
13.
Wang, Fu, Tao Zhang, Huijie Zhang, et al.. (2016). Relation of Birth Weight to Heart Rate in Childhood, Adolescence, and Adulthood (from the Bogalusa Heart Study). The American Journal of Cardiology. 118(6). 828–832. 5 indexed citations
14.
Wang, Fu. (2012). A tentative discussion on ore-controlling factors,ore genesis and metallogenic model of Houwanling Pb-Zn deposit in Hainan Province. Mineralium Deposita. 2 indexed citations
15.
Wang, Fu. (2004). Surveillance of bacterial resistance in Gram-positive cocci. 1 indexed citations
16.
Zhang, Yingyuan, et al.. (2004). In vitro activities of tigecycline against clinical isolates from Shanghai, China. Diagnostic Microbiology and Infectious Disease. 50(4). 267–281. 30 indexed citations
17.
Wang, Fu, et al.. (2003). The susceptibility of non-fermentative Gram-negative bacilli to cefperazone and sulbactam compared with other antibacterial agents. International Journal of Antimicrobial Agents. 22(4). 444–448. 8 indexed citations
18.
Zhu, Demei, et al.. (2002). Investigation of extended-spectrum β-lactamase in Klebsiellae pneumoniae and Escherichia coli from China. Diagnostic Microbiology and Infectious Disease. 44(2). 195–200. 51 indexed citations
19.
Wang, Minggui, Yingyuan Zhang, Demei Zhu, & Fu Wang. (2001). Prevalence and phenotypes of erythromycin-resistant Streptococcus pneumoniae in Shanghai, China. Diagnostic Microbiology and Infectious Disease. 39(3). 187–189. 8 indexed citations
20.
Wang, Fu. (1999). Antilipid peroxidation and protective effects of dltetrahydropalmatine on ischemia reperfusion neurological damage and abnormal behavior in rats. Zhongguo yaolixue tongbao. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hee Bong Shin Breakdown of academic impact, for papers by Ju‐Hsin Chia Breakdown of academic impact, for papers by Ya‐Sung Yang Breakdown of academic impact, for papers by Fernando Docobo-Pérez Breakdown of academic impact, for papers by Han-Sung Kim Breakdown of academic impact, for papers by Anna Di Popolo Breakdown of academic impact, for papers by Hadir A. El‐Mahallawy Breakdown of academic impact, for papers by Francis S. Codjoe Breakdown of academic impact, for papers by Nan Bai Breakdown of academic impact, for papers by Paul Pantapalangkoor
Rankless by CCL
2026